Dysregulated Airway Epithelial Signaling as a Driver of Airway Remodeling in Asthmatic Children
Dysregulated Airway Epithelial Signaling as a Driver of Airway Remodeling in Asthmatic Children
批准号:
9130413
负责人:
JASON S DEBLEY
金额:
$48.25万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-01 至 2016-08-31
关键词:
ActivinsAdrenal Cortex HormonesAdultAnimal ModelAnimalsAntibodiesAsthmaBasement membraneBiological ModelsBiopsyBreathingCell modelCellsChildChildhoodClinicalCoculture TechniquesCollagenDataDepositionDevelopmentDinoprostoneDown-RegulationEnvironmentEpidemiologic StudiesEpithelialEpithelial CellsEquilibriumExhibitsExtracellular MatrixFibroblastsFollistatinFutureGenesGrowth FactorHealthHumanHyaluronanInterventionLungMediatingModelingMorbidity - disease rateMyofibroblastNatural HistoryProductionProteinsProteoglycanPulmonary FibrosisRecording of previous eventsRegulationReportingRespiratory physiologySeveritiesSignal TransductionTestingTransforming Growth Factor betaVirus Diseasesactivin Aairborne allergenairway remodelingasthmaticasthmatic airwaybasebronchial epitheliumearly childhoodimprovedin vivoinhibitor/antagonistinnovationinterstitialneutralizing antibodypreventreceptorresearch studysmall hairpin RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Epidemiologic studies have revealed that asthmatic children have lower lung function during childhood that persists into adulthood compared to healthy children. Bronchial biopsies from asthmatic children demonstrate that features of airway remodeling, including excessive sub-epithelial extracellular matrix deposition (e.g. collagens, hyaluronan), are already present in early childhood. Together, these data suggest that early structural changes in the asthmatic airway may contribute to lung function declines that manifest early in the natural history of asthma. Although inhaled corticosteroids reduce morbidity, treatment does not alter the natural history of asthma nor prevent decline in lung function. Improved understanding of mechanisms that drive airway remodeling is fundamental to the development of future clinical interventions to alter the natural course of asthma and prevent lung function decline. Airway epithelial cells are the first point of contact between the environment and the host lung. Evidence from animal models and human bronchial biopsies suggest that the bronchial epithelium secretes a number of proteins that may regulate lung fibroblasts and airway remodeling. Our group has demonstrated that primary airway epithelial cells from asthmatic children intrinsically exhibit greater expression of candidate pro-remodeling factors, when compared to healthy epithelial cells. We have also reported that in co-culture airway epithelial cells from healthy children markedly down-regulate lung fibroblast expression of extracellular matrix components involved in airway remodeling. In contrast, this down-regulation is significantly less when fibroblasts are co-cultured with asthmatic epithelial cells. Preliminary data from our human airway epithelial cell model systems suggest prostaglandin E2 (PGE2) and the activin inhibitor follistatin-like-3 (FSTL3) as epithelial-secreted proteins that ma tonically inhibit fibroblast function. We propose to use innovative airway epithelial cell/fibroblat co-culture model systems with primary bronchial epithelial cells from well-characterized asthmatic and healthy children to test our hypothesis that in normal airways a balance of epithelial-derived stimulatory and inhibitory factors regulates fibroblasts and inhibits airway interstitial extracellular matrix deposition involved in airway remodeling. We will test our hypothesis that expression of these factors is dysregulated in asthma, specifically with increased TGFß2 and activin A, as well as decreased PGE2 and FSTL3 expression by asthmatic epithelial cells, leading to increased fibroblast proliferation and extracellular matrix expression. Finally, we will test our hypotheses that fibroblast proliferation and expression of extracellular matrix constituents and epithelial secretion of TGFß2, activin A, PGE2 and FSTL3, in asthmatic co-cultures are associated with asthma severity, asthma exacerbations, and/or lung function among the asthmatic children who donated airway epithelial cells used in co-culture experiments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
-
批准号:10558633
-
项目类别:
-
资助金额:$86.39万
-
财政年份:2022
-
负责人:JASON S DEBLEY
-
依托单位:
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
-
批准号:10446799
-
项目类别:
-
资助金额:$91.94万
-
财政年份:2022
-
负责人:JASON S DEBLEY
-
依托单位:
Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium
-
批准号:10265757
-
项目类别:
-
资助金额:$6.72万
-
财政年份:2020
-
负责人:JASON S DEBLEY
-
依托单位:
Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium
-
批准号:10552683
-
项目类别:
-
资助金额:$18.45万
-
财政年份:2020
-
负责人:JASON S DEBLEY
-
依托单位:
Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium
-
批准号:10330561
-
项目类别:
-
资助金额:$18.45万
-
财政年份:2020
-
负责人:JASON S DEBLEY
-
依托单位:
NONINVASIVE MEASURES OF AIRWAY INFLAMMAITON AND AIRFLOW OBSTRUCTION IN WHEEZY
-
批准号:7603558
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2007
-
负责人:JASON S DEBLEY
-
依托单位:
AIRFLOW OBSTRUCTION AND BIOMARKERS OF AIRWAY DURING AND FOLLOWING OF ASTHMA
-
批准号:7603551
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2007
-
负责人:JASON S DEBLEY
-
依托单位:
AIRFLOW OBSTRUCTION AND BIOMARKERS OF AIRWAY INFLAMATION
-
批准号:7379438
-
项目类别:
-
资助金额:$1.98万
-
财政年份:2006
-
负责人:JASON S DEBLEY
-
依托单位:
Noninvasive Measures in Wheezy Infants and Toddlers
-
批准号:6956540
-
项目类别:
-
资助金额:$12.66万
-
财政年份:2005
-
负责人:JASON S DEBLEY
-
依托单位:
Noninvasive Measures in Wheezy Infants and Toddlers
-
批准号:7103668
-
项目类别:
-
资助金额:$12.66万
-
财政年份:2005
-
负责人:JASON S DEBLEY
-
依托单位:
Noninvasive Measures in Wheezy Infants and Toddlers
-
批准号:7667767
-
项目类别:
-
资助金额:$12.66万
-
财政年份:2005
-
负责人:JASON S DEBLEY
-
依托单位:
IBUPROFEN PROVOCATION CHALLENGE IN ASTHMATIC CHILDREN
-
批准号:7198813
-
项目类别:
-
资助金额:$1.07万
-
财政年份:2005
-
负责人:JASON S DEBLEY
-
依托单位:
Noninvasive Measures in Wheezy Infants and Toddlers
-
批准号:7258924
-
项目类别:
-
资助金额:$12.66万
-
财政年份:2005
-
负责人:JASON S DEBLEY
-
依托单位:
ASSESSMENT OF THORACIC INDEX AS A REFLECTION OF PULMONARY HYPERINFLATION
-
批准号:7198888
-
项目类别:
-
资助金额:$0.21万
-
财政年份:2005
-
负责人:JASON S DEBLEY
-
依托单位:
Noninvasive Measures in Wheezy Infants and Toddlers
-
批准号:7691866
-
项目类别:
-
资助金额:$2.86万
-
财政年份:2005
-
负责人:JASON S DEBLEY
-
依托单位:
Noninvasive Measures in Wheezy Infants and Toddlers
-
批准号:7469376
-
项目类别:
-
资助金额:$12.66万
-
财政年份:2005
-
负责人:JASON S DEBLEY
-
依托单位:
Thoracic Index as a Reflection of Pulmonary Hyperinflation in Infants with RSV
-
批准号:6974586
-
项目类别:
-
资助金额:$5.2万
-
财政年份:2004
-
负责人:JASON S DEBLEY
-
依托单位:
Ibuprofen Provocation Challenge in Asthmatic Children
-
批准号:6974522
-
项目类别:
-
资助金额:$8.8万
-
财政年份:2004
-
负责人:JASON S DEBLEY
-
依托单位:
Core B: Primary Airway Epithelial Cell Culture Core
-
批准号:9315102
-
项目类别:
-
资助金额:$32.89万
-
财政年份:--
-
负责人:JASON S DEBLEY
-
依托单位:
Core B: Primary Airway Epithelial Cell Culture Core
-
批准号:9157671
-
项目类别:
-
资助金额:$44.38万
-
财政年份:--
-
负责人:JASON S DEBLEY
-
依托单位: